Sellas Life Sciences Group Inc (SLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 10,629 | 9,252 | 8,255 | 7,083 | 6,873 |
| Operating Income | -10,629 | -9,252 | -8,255 | -7,083 | -6,873 |
| Other Income | 1,024 | 845 | 597 | 292 | 272 |
| Pre-tax Income | -9,605 | -8,407 | -7,658 | -6,791 | -6,601 |
| Net Income Continuous | -9,605 | -8,407 | -7,658 | -6,791 | -6,601 |
| Net Income | $-9,605 | $-8,407 | $-7,658 | $-6,791 | $-6,601 |
| EPS Basic Total Ops | -0.05 | -0.05 | -0.05 | -0.06 | -0.07 |
| EPS Basic Continuous Ops | -0.05 | -0.05 | -0.05 | -0.06 | -0.07 |
| EPS Diluted Total Ops | -0.05 | -0.05 | -0.05 | -0.06 | -0.07 |
| EPS Diluted Continuous Ops | -0.05 | -0.05 | -0.05 | -0.06 | -0.07 |
| EPS Diluted Before Non-Recurring Items | -0.05 | -0.05 | -0.05 | -0.06 | -0.07 |
| EBITDA(a) | $-10,629 | $-9,252 | $-8,255 | $-7,083 | $-6,873 |